Adjustment of drug dose for rheumatoid arthritis by diagnostic method
Determination of the therapeutic window of adalimumab
06-Oct-2017 -
Collaboration between the Immanuel Klinikum Bernau Herzzentrum Brandenburg, the Rheumazentrum Nord-Brandenburg and BioTeZ demonstrates new ways of treating rheumatoid arthritis.
Through the introduction of therapeutic antibodies, the treatment results for rheumatoid arthritis (RA) have been ...
active substances
adalimumab
arthritis
+5